| Trial ID: | L1318 |
| Source ID: | NCT00428246
|
| Associated Drug: |
Paricalcitol
|
| Title: |
Study of Protective Effects of Paricalcitol on Inner Layer of Vessels and Its Protective Effect on Inflammation
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00428246/results
|
| Conditions: |
Chronic Kidney Disease|Endothelial Dysfunction|Inflammation|Hypertension
|
| Interventions: |
DRUG: paricalcitol|DRUG: Placebo
|
| Outcome Measures: |
Primary: Anti-Inflammatory Effects of Paricalcitol, change in hsCRP level from baseline to 4 weeks, 6 weeks|Endothelial Protectant Effects of Paricalcitol, 6 weeks | Secondary: Effect of Paricalcitol on Hypertension, 6 weeks|Effect of Paricalcitol on Kidney Function, 6 weeks
|
| Sponsor/Collaborators: |
Sponsor: Indiana University School of Medicine | Collaborators: Abbott
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
24
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2006-11
|
| Completion Date: |
2007-07
|
| Results First Posted: |
2009-06-03
|
| Last Update Posted: |
2009-06-03
|
| Locations: |
Richard A. Rodebush VA Medical Center, Indianapolis, Indiana, 46202, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00428246
|
